INNFOCUS, INC.

Profile

Company Names

INNFOCUS, INC.

Addresses

12415 SW 136 AVENUE, SUITE #3, MIAMI, FL 33186

12415 SW 136 AVENUE, UNIT 3, MIAMI, FL 33186

Phone Numbers

305-378-2651

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$48,327,821.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2015-09-21 
$32,823,257.00 
$35,999,947.00 
$3,176,690.00 
Equity 
2
2013-06-05 
$13,504,564.00 
$16,504,700.00 
$3,000,136.00 
Equity 
1
2011-06-15 
$2,000,000.00 
$2,280,000.00 
$280,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SCOTT 
 
HALSTED 
DIRECTOR
EPITEK, INC   |  ANGIOSCORE INC.   |  INNFOCUS, INC.   |  LEERINK REVELATION HEALTHCARE FUND I, L.P.   |  OPTISCAN BIOMEDICAL CORP   |  INTELYCARE, INC.
CHERYL 
 
JACKMAN 
EXECUTIVE OFFICER
INNFOCUS, INC.
CHRISTIAN 
 
MAZZOLA 
DIRECTOR
INNFOCUS, INC.
DIANE 
F. 
PINCHUK 
EXECUTIVE OFFICER
INNFOCUS, INC.
LEONARD 
 
PINCHUK 
EXECUTIVE OFFICER, DIRECTOR
INNFOCUS, INC.
LEONARD 
 
PINCHUK, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
INNFOCUS, INC.
JOHN 
W. 
SHEETS, JR. 
DIRECTOR
INNFOCUS, INC.
C. RUSSELL 
 
TRENARY, III 
EXECUTIVE OFFICER, DIRECTOR
INNFOCUS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2015-10-01
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-21 
2013-08-08
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-05 
2011-06-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-06-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#